A detailed history of Axq Capital, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Axq Capital, LP holds 2,599 shares of ABT stock, worth $298,261. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,599
Previous 6,251 58.42%
Holding current value
$298,261
Previous $650 Million 54.38%
% of portfolio
0.09%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $365,455 - $431,410
-3,652 Reduced 58.42%
2,599 $296 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $629,663 - $702,862
6,251 New
6,251 $650 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $477,650 - $573,100
5,000 New
5,000 $484 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $686,998 - $805,955
7,227 New
7,227 $793 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.